The problem with Silicon Valley medicine

The biotechnology sector is based on the premise that we can “hack” our biology, but that risks oversimplifying disease and medicalising normal physiology, writes Rohin Francis

Saved in:
Bibliographic Details
Published inBMJ (Online) Vol. 381; p. 1257
Main Author Francis, Rohin
Format Journal Article
LanguageEnglish
Published England British Medical Journal Publishing Group 02.06.2023
BMJ Publishing Group LTD
Subjects
Biotechnology
Biotechnology industry
Blood tests
Diabetes
Environment
Glucose
Humans
Medicine
Opinion
United States > US
Silicon Valley-California
Online AccessGet full text

Cover

More Information
Summary:The biotechnology sector is based on the premise that we can “hack” our biology, but that risks oversimplifying disease and medicalising normal physiology, writes Rohin Francis
Bibliography:SourceType-Other Sources-1
content type line 63
ObjectType-Editorial-2
ObjectType-Commentary-1
ISSN:1756-1833
1756-1833
DOI:10.1136/bmj.p1257